Methotrexate

Response to: ‘Metering the METEOR in methotrexate failure: is propensity score a falling star?’ by Ahmed et al
Sytske Anne Bergstra, Cornelia F Allaart, Robert B M Landewé

Annals of the Rheumatic Diseases Dec 2019, 78 (12) e132; DOI: 10.1136/annrheumdis-2018-214652
Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response
Roy M Fleischmann, Mark C Genovese, Jeffrey V Enejosa, Eduardo Mysler, Louis Bessette, Charles Peterfy, Patrick Durez, Andrew Ostor, Yihan Li, In-Ho Song

Annals of the Rheumatic Diseases Nov 2019, 78 (11) 1454-1462; DOI: 10.1136/annrheumdis-2019-215764
Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan
Tsutomu Takeuchi, Yoshiya Tanaka, Sakae Tanaka, Atsushi Kawakami, Manabu Iwasaki, Kou Katayama, Mitsuhiro Rokuda, Hiroyuki Izutsu, Satoshi Ushijima, Yuichiro Kaneko, Teruaki Shiomi, Emi Yamada, Désirée van der Heijde

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1305-1319; DOI: 10.1136/annrheumdis-2019-215164
Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials
Maxime MA Verhoeven, Marjolein JH de Hair, Janneke Tekstra, Johannes WJ Bijlsma, Jacob M van Laar, Attila Pethoe-Schramm, Michelle EA Borm, Evert-Jan ter Borg, Suzanne P Linn-Rasker, Xavier M Teitsma, Floris PJG Lafeber, Johannes WG Jacobs, Paco MJ Welsing

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1333-1338; DOI: 10.1136/annrheumdis-2019-215304
Development and validation of a methotrexate adherence assay
James Bluett, Isabel Riba-Garcia, Suzanne M M Verstappen, Thierry Wendling, Kayode Ogungbenro, Richard D Unwin, Anne Barton

Annals of the Rheumatic Diseases Sep 2019, 78 (9) 1192-1197; DOI: 10.1136/annrheumdis-2019-215446
Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial
Jin Kyun Park, Yunhee Choi, Kevin L Winthrop, Yeong Wook Song, Eun Bong Lee

Annals of the Rheumatic Diseases Sep 2019, 78 (9) 1283-1284; DOI: 10.1136/annrheumdis-2019-215187
Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept
Thierry Dervieux, Joel M Kremer, Michael E Weinblatt

Annals of the Rheumatic Diseases Sep 2019, 78 (9) 1285-1286; DOI: 10.1136/annrheumdis-2018-214860
Can we further SPARkle the SPAR model?
Chengappa G Kavadichanda, Vir Singh Negi

Annals of the Rheumatic Diseases Sep 2019, 78 (9) e93; DOI: 10.1136/annrheumdis-2018-213954
Response to: ‘Can we further SPARkle the SPAR model?’ by Kavadichanda et al
Wanlong Wu, Suzana Jordan, Oliver Distler

Annals of the Rheumatic Diseases Sep 2019, 78 (9) e94; DOI: 10.1136/annrheumdis-2018-213962
Consensus-based recommendations for the management of juvenile localised scleroderma
Francesco Zulian, Roberta Culpo, Francesca Sperotto, Jordi Anton, Tadej Avcin, Eileen M Baildam, Christina Boros, Jeffrey Chaitow, Tamàs Constantin, Ozgur Kasapcopur, Sheila Knupp Feitosa de Oliveira, Clarissa A Pilkington, Ricardo Russo, Natasa Toplak, Annet van Royen, Claudia Saad Magalhães, Sebastiaan J Vastert, Nico M Wulffraat, Ivan Foeldvari

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1019-1024; DOI: 10.1136/annrheumdis-2018-214697

Main menu

Methotrexate

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Methotrexate

Pages